TABLE 2.
Females (mean ± SEM) |
Males (mean ± SEM) |
|||||
Asp289 (n = 14) | Glu298 (n = 15) | Asp289 (n = 15) | Glu298 (n = 15) | P between Genotypes | P between Genders | |
Age (y) | 27.6 ± 3.07 | 27.1 ± 2.98 | 28.5 ± 3.54 | 28.4 ± 3.46 | 0.995 | 0.734 |
BMI (kg/m2) | 22.4 ± 0.2 | 22.5 ± 0.2 | 24.1 ± 0.2 | 23.8 ± 0.2 | 0.893 | 0.069 |
Blood pressure | ||||||
Systolic (mmHg) | 118.6 ± 0.5 | 118.2 ± 0.5 | 129.7 ± 0.5 | 127.0 ± 0.6 | 0.514 | <0.001 |
Diastolic (mmHg) | 77.2 ± 0.6 | 76.3 ± 0.6 | 76.1 ± 0.6 | 75.6 ± 0.7 | 0.746 | 0.699 |
Baseline plasma NEFA composition | ||||||
SFA (%) | 38.5 ± 0.8 | 39.3 ± 1.1 | 38.6 ± 0.8 | 37.9 ± 0.8 | 0.983 | 0.438 |
MUFA (%) | 37.1 ± 1.4 | 35.3 ± 2.5 | 37.3 ± 1.2 | 38.2 ± 0.8 | 0.783 | 0.336 |
n-6 PUFA (%) | 12.9 ± 0.5 | 13.9 ± 0.8 | 12.2 ± 0.4** | 14.0 ± 0.5 | 0.019 | 0.681 |
LC n-3 PUFA (%) | 1.4 ± 0.2 | 1.5 ± 0.2 | 1.6 ± 0.2 | 1.5 ± 0.2 | 0.945 | 0.810 |
Baseline plasma PC composition | ||||||
SFA (%) | 40.8 ± 0.4 | 39.9 ± 0.4 | 39.8 ± 0.5 | 39.0 ± 0.6 | 0.080 | 0.048 |
MUFA (%) | 10.7 ± 0.5 | 9.7 ± 0.3 | 35.3 ± 0.4 | 10.3 ± 0.3 | 0.323 | 0.790 |
n-6 PUFA (%) | 30.0 ± 0.5 | 28.8 ± 0.4 | 29.1 ± 0.5 | 28.3 ± 0.5 | 0.316 | 0.693 |
LC n-3 PUFA (%) | 3.9 ± 0.4 | 4.3 ± 0.3 | 4.5 ± 0.3 | 4.1 ± 0.2 | 0.966 | 0.623 |
Statistical significance of difference between genotypes within a gender: **P ≤ 0.01. Bold text indicates significant P-values.